The investment-grade notes are due 2032

Davis Polk advised the representatives of the several underwriters in connection with the debut, SEC-registered notes offering by Kenvue Inc. of $750 million aggregate principal amount of its 4.850% senior notes due 2032.

Kenvue is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, its iconic brands – including Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena and Tylenol – are science-backed and recommended by healthcare professionals around the world. Kenvue realizes the extraordinary power of everyday care and works to put that power in consumers’ hands, earning a place in their hearts and homes.

The Davis Polk capital markets team included partners John B. Meade and Roshni Banker Cariello, counsel Arisa Akashi Sin and associates Marquis J. Pullen and Adam Pukier. All members of the Davis Polk team are based in the New York office.

Copy link to share post